Yazar "Satıcı, Celal" için listeleme

Toplam kayıt 2, listelenen: 1-2

Long acting B-2 agonists (LABA) or anticholinergics (LAMA): Which one is more efficient in Group A COPD patients?

Turan, Muzaffer Onur; Ogan, Nalan; Bozkuş, Fulsen; Sarıoğlu, Nurhan; Turan, Pakize Ayşe; Satıcı, Celal (European Respiratory Soc Journals Ltd, 2021)

Introduction: Long-acting anticholinergic (LAMA) or beta-2 agonists (LABA) for symptom control in symptomatic group A COPD patients in GOLD guideline, however, there is no mention of priority or superiority between the two ...
Long-acting B-2 agonists (LABA) or long-acting muscarinic antagonists (LAMA): Which one may be the first option in group A COPD patients?

Turan, Muzaffer Onur; Ogan, Nalan; Bozkuş, Fulsen; Sarıoglu, Nurhan; Turan, Pakize Ayşe; Satıcı, Celal (Springer Heidelberg, 2024)

IntroductionLong-acting muscarinic antagonists (LAMA) or beta-2 agonists (LABA) have been recommended for symptom control in group A COPD patients as a first-line bronchodilator treatment in GOLD guidelines. However, there ...